EASY BIO,Inc. (KOSDAQ: 353810)
South Korea
· Delayed Price · Currency is KRW
3,600.00
+210.00 (6.19%)
Nov 15, 2024, 9:00 AM KST
EASY BIO,Inc. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue | 245,532 | 165,385 | 155,557 | 129,458 |
Revenue Growth (YoY) | 51.53% | 6.32% | 20.16% | - |
Cost of Revenue | 172,477 | 113,682 | 108,612 | 89,388 |
Gross Profit | 73,055 | 51,703 | 46,945 | 40,070 |
Selling, General & Admin | 41,785 | 27,710 | 26,952 | 20,575 |
Research & Development | 2,863 | 2,487 | 2,426 | 1,744 |
Other Operating Expenses | 1,059 | 268.54 | 217.04 | 167.89 |
Operating Expenses | 47,593 | 31,072 | 30,790 | 23,291 |
Operating Income | 25,463 | 20,631 | 16,155 | 16,779 |
Interest Expense | -5,425 | -3,219 | -1,720 | -1,105 |
Interest & Investment Income | 1,959 | 1,333 | 534.54 | 347.87 |
Currency Exchange Gain (Loss) | 296.01 | 981.1 | -1,670 | -160.27 |
Other Non Operating Income (Expenses) | -1,925 | -1,878 | -1,907 | -1,821 |
EBT Excluding Unusual Items | 20,369 | 17,848 | 11,392 | 14,041 |
Gain (Loss) on Sale of Investments | 2,877 | 2,224 | 592.15 | 12.04 |
Gain (Loss) on Sale of Assets | 6.01 | -7.04 | -0.33 | 0.9 |
Pretax Income | 23,252 | 20,066 | 11,984 | 14,054 |
Income Tax Expense | 5,532 | 3,965 | 2,637 | 3,212 |
Earnings From Continuing Operations | 17,720 | 16,101 | 9,347 | 10,842 |
Minority Interest in Earnings | -383.66 | -557.26 | -216.61 | 30.73 |
Net Income | 17,336 | 15,544 | 9,131 | 10,873 |
Net Income to Common | 17,336 | 15,544 | 9,131 | 10,873 |
Net Income Growth | 45.32% | 70.24% | -16.02% | - |
Shares Outstanding (Basic) | 34 | 34 | 34 | 34 |
Shares Outstanding (Diluted) | 34 | 34 | 34 | 34 |
Shares Change (YoY) | -0.01% | - | 0.16% | - |
EPS (Basic) | 507.88 | 455.33 | 267.47 | 319.00 |
EPS (Diluted) | 507.55 | 455.00 | 267.00 | 319.00 |
EPS Growth | 45.44% | 70.41% | -16.30% | - |
Free Cash Flow | 27,778 | 31,798 | -10,079 | 12,231 |
Free Cash Flow Per Share | 813.79 | 931.49 | -295.24 | 358.86 |
Dividend Per Share | 100.000 | 100.000 | 75.000 | - |
Dividend Growth | 33.33% | 33.33% | - | - |
Gross Margin | 29.75% | 31.26% | 30.18% | 30.95% |
Operating Margin | 10.37% | 12.47% | 10.39% | 12.96% |
Profit Margin | 7.06% | 9.40% | 5.87% | 8.40% |
Free Cash Flow Margin | 11.31% | 19.23% | -6.48% | 9.45% |
EBITDA | 29,761 | 24,323 | 19,918 | 19,580 |
EBITDA Margin | 12.12% | 14.71% | 12.80% | 15.12% |
D&A For EBITDA | 4,298 | 3,692 | 3,763 | 2,801 |
EBIT | 25,463 | 20,631 | 16,155 | 16,779 |
EBIT Margin | 10.37% | 12.47% | 10.39% | 12.96% |
Effective Tax Rate | 23.79% | 19.76% | 22.00% | 22.85% |
Advertising Expenses | - | 830.48 | 690.36 | 342.02 |
Source: S&P Capital IQ. Standard template. Financial Sources.